131 related articles for article (PubMed ID: 9028723)
1. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. The Sardinian Diabetes Genetic Study Group.
Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Maioli M; Pala G; Massidda A; Manai M; Pilosu RM; Li LS; Luthman H; Maioli M
Diabetologia; 1997 Jan; 40(1):89-94. PubMed ID: 9028723
[TBL] [Abstract][Full Text] [Related]
2. Role of the Gly40Ser mutation in the glucagon receptor gene in Brazilian patients with type 2 diabetes mellitus.
Shiota D; Kasamatsu T; Dib SA; Chacra AR; Moisés RS
Pancreas; 2002 May; 24(4):386-90. PubMed ID: 11961492
[TBL] [Abstract][Full Text] [Related]
3. Glucagon receptor Gly40Ser amino acid variant in Sardinian hypertensive non-insulin-dependent diabetic patients. Sardinian Diabetic Genetic Study Group (SDGSG).
Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Li LS; Luthman H; Maioli M
Acta Diabetol; 1997 Aug; 34(2):75-6. PubMed ID: 9325468
[TBL] [Abstract][Full Text] [Related]
4. Restricted geographical extension of the association of a glucagon receptor gene mutation (Gly40Ser) with non-insulin-dependent diabetes mellitus.
Ristow M; Busch K; Schatz H; Pfeiffer A
Diabetes Res Clin Pract; 1996 May; 32(3):183-5. PubMed ID: 8858207
[TBL] [Abstract][Full Text] [Related]
5. A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus.
Fujisawa T; Ikegami H; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Fukuda M; Ogihara T
Diabetologia; 1995 Aug; 38(8):983-5. PubMed ID: 7589886
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland.
Huang X; Orho M; Lehto M; Groop L
Diabetologia; 1995 Oct; 38(10):1246-8. PubMed ID: 8690179
[TBL] [Abstract][Full Text] [Related]
7. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.
Hansen LH; Abrahamsen N; Hager J; Jelinek L; Kindsvogel W; Froguel P; Nishimura E
Diabetes; 1996 Jun; 45(6):725-30. PubMed ID: 8635644
[TBL] [Abstract][Full Text] [Related]
8. [Gly40Ser mutation of glucagon receptor gene and NIDDM in Han nationality].
Deng H; Tang WL; Pan Q
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):291-3. PubMed ID: 12536714
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the glucagon receptor gene and non-insulin-dependent diabetes mellitus in the Russian population.
Babadjanova G; Reincke M; Mora P; Chuchalin A; Allolio B
Exp Clin Endocrinol Diabetes; 1997; 105(4):225-6. PubMed ID: 9285210
[TBL] [Abstract][Full Text] [Related]
10. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus.
Hager J; Hansen L; Vaisse C; Vionnet N; Philippi A; Poller W; Velho G; Carcassi C; Contu L; Julier C
Nat Genet; 1995 Mar; 9(3):299-304. PubMed ID: 7773293
[TBL] [Abstract][Full Text] [Related]
11. Screening for the Gly40Ser mutation in the glucagon receptor gene among patients with type 2 diabetes or essential hypertension in Taiwan.
Huang CN; Lee KC; Wu HP; Tai TY; Lin BJ; Chuang LM
Pancreas; 1999 Mar; 18(2):151-5. PubMed ID: 10090412
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a German non-insulin-dependent diabetes mellitus population.
Ambrosch A; Lobmann R; Dierkes J; König W; Luley C; Lehnert H
Clin Chem Lab Med; 1999 Jul; 37(7):719-21. PubMed ID: 10510728
[TBL] [Abstract][Full Text] [Related]
13. Absence of the Gly40-ser mutation in the glucagon receptor gene in Japanese subjects with NIDDM.
Ogata M; Iwasaki N; Ohgawara H; Karibe S; Omori Y
Diabetes Res Clin Pract; 1996 Jul; 33(2):71-4. PubMed ID: 8879960
[TBL] [Abstract][Full Text] [Related]
14. Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients.
Odawara M; Matsunuma A; Yamashita K
Diabetes Care; 1996 May; 19(5):547. PubMed ID: 8732726
[No Abstract] [Full Text] [Related]
15. Renal potassium handling in carriers of the Gly40Ser mutation of the glucagon receptor suggests a role for glucagon in potassium homeostasis.
Bankir L; Barbato A; Russo O; Crambert G; Iacone R; Bouby N; Perna L; Strazzullo P
Physiol Rep; 2018 Apr; 6(8):e13661. PubMed ID: 29671960
[TBL] [Abstract][Full Text] [Related]
16. Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance.
Odawara M; Tachi Y; Yamashita K
Hum Genet; 1996 Dec; 98(6):636-9. PubMed ID: 8931690
[TBL] [Abstract][Full Text] [Related]
17. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
[TBL] [Abstract][Full Text] [Related]
19. Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population.
Tonolo G; Melis MG; Secchi G; Atzeni MM; Angius MF; Carboni A; Ciccarese M; Malavasi A; Maioli M
J Hypertens; 1999 Jan; 17(1):33-8. PubMed ID: 10100091
[TBL] [Abstract][Full Text] [Related]
20. Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: the PEGASE study.
Brand E; Bankir L; Plouin PF; Soubrier F
Hypertension; 1999 Jul; 34(1):15-7. PubMed ID: 10406817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
